Kovalovsky, Damian http://orcid.org/0000-0002-7040-8592
Yoon, Jeong Heon
Cyr, Matthew G.
Simon, Samantha
Voynova, Elisaveta
Rader, Christoph http://orcid.org/0000-0001-9955-3454
Wiestner, Adrian
Alejo, Julie
Pittaluga, Stefania
Gress, Ronald E.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (600897, 600897, 600897, 600897)
Bench to bedside and back program. Office of clinical Research, NIH
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 27 April 2020
Revised: 21 January 2021
Accepted: 3 February 2021
First Online: 25 February 2021
Compliance with ethical standards
:
: CR is an inventor of U.S. Patent 8,877,199 which claims monoclonal antibody JML1. All other authors declare no competing interests.